Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy
Clinical trial NCT02913482 · COMPLETED
Trial details
- NCT number
- NCT02913482
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-23
- Primary completion
- 2019-11-14
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.